Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong
· Delayed Price · Currency is HKD 12.12
+0.44 (3.77%)
Apr 28, 2025, 4:08 PM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 4.66 billion as of April 28, 2025. Its market cap has increased by 35.03% in one year.
Market Cap
4.66B
Enterprise Value
4.84B
Revenue
1.04B
Ranking
n/a
PE Ratio
130.24
Stock Price
12.12
Market Cap Chart
Since September 1, 2022, HKG:2315's market cap has decreased from 10.31B to 4.66B, a decrease of -54.77%. That is a compound annual growth rate of -25.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 4.66B | 37.41% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 204.71B |
| Hansoh Pharmaceutical Group Company | 142.11B |
| JD Health International | 114.63B |
| WuXi Biologics | 92.39B |
| Innovent Biologics | 89.58B |
| Akeso | 88.77B |
| Alibaba Health Information Technology | 74.78B |
| Sino Biopharmaceutical | 70.68B |